Ikena Oncology Inc.

NASDAQ: IKNA · Real-Time Price · USD
17.16
15.79 (1152.55%)
At close: Jul 25, 2025, 3:59 PM

Ikena Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a 659K 1.19M 2M 5.31M 5.45M 6.4M 382K 3.38M 20.22M 3.75M 3.55M 3.47M
Cost of Revenue
n/a n/a n/a n/a 92K 219K 305K 242K 586K n/a 381K 18.85M 15.49M 14.34M 12.34M 13.38M 11.37M 10.02M
Gross Profit
n/a n/a n/a n/a -92K -219K 354K 943K 1.42M 5.31M 5.07M -12.45M -15.11M -10.96M 7.88M -9.63M -7.83M -6.55M
Operating Income
-8.75M -10.79M -12.52M -12.41M -15.14M -15.64M -21.91M -19.5M -18.49M -15.52M -15.11M -17.88M -20.95M -16.96M 2.79M -14.52M -12.69M -9.72M
Interest Income
n/a n/a n/a n/a n/a n/a 2.27M 2.16M 1.38M 730K 893K 576K 507K 172K n/a 7K 6K 4K
Pretax Income
-2.75M -8.59M -9.07M -10.22M -13.67M -16.12M -19.65M -17.34M -17.11M -14.22M -14.1M -17.34M -20.49M -16.84M 2.8M -14.52M -12.68M -9.72M
Net Income
-2.77M -8.62M -9.12M -10.23M -13.73M -16.15M -19.49M -17.34M -17.11M -14.22M -13.08M -16.8M -20.03M -16.72M 2.8M -14.52M -12.68M -9.72M
Selling & General & Admin
4.42M 5.64M 7.59M 4.78M 5.31M 6M 8.29M 6.03M 5.32M 5.28M 4.92M 5.43M 5.84M 6M 5.09M 4.89M 4.86M 3.17M
Research & Development
4.03M 3.71M 4.58M 6.82M 9.74M 9.43M 13.97M 1.19M 15.17M 15.55M 15.64M 18.85M 15.49M 14.34M 12.34M 13.38M 11.37M 10.02M
Other Expenses
309K 1.44M 342K 812K n/a -7K -14K 13.47M -6K n/a 124K -38K -47K -49K 5K 7K 6K 4K
Operating Expenses
8.75M 10.79M 12.52M 12.41M 15.05M 15.43M 22.26M 20.69M 20.49M 20.83M 20.56M 24.28M 21.33M 20.35M 17.43M 18.27M 16.24M 13.19M
Interest Expense
n/a n/a n/a n/a n/a n/a 1.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 10.79M 12.52M 12.41M 15.14M 15.64M 22.57M 20.69M 20.49M 20.83M 20.56M 24.28M 21.33M 20.35M 17.43M 18.27M 16.24M 13.19M
Income Tax Expense
-15K -28K 53K 10K 62K 27K -162K n/a n/a n/a -1.02M -538K -460K -123K n/a n/a n/a n/a
Shares Outstanding (Basic)
48.26M 48.26M 48.26M 48.26M 48.26M 48.26M 47.81M 43.44M 39.29M 36.26M 36.26M 36.26M 36.16M 36.08M 35.86M 35.86M 35.85M 3.85M
Shares Outstanding (Diluted)
48.26M 48.26M 48.26M 48.26M 48.26M 48.26M 47.81M 43.44M 39.29M 36.26M 36.26M 36.26M 36.16M 36.08M 35.86M 35.86M 35.85M 3.85M
EPS (Basic)
-0.06 -0.18 -0.21 -0.21 -0.28 -0.33 -0.41 -0.4 -0.44 -0.39 -0.36 -0.46 -0.55 -0.46 0.08 -0.4 -0.35 -2.52
EPS (Diluted)
-0.06 -0.18 -0.21 -0.21 -0.28 -0.33 -0.41 -0.4 -0.44 -0.39 -0.36 -0.46 -0.55 -0.46 0.08 -0.4 -0.35 -2.52
EBITDA
-8.75M -9.27M -12.09M -11.51M -15.05M -15.43M -21.6M -19.26M -18.25M -15.28M -14.9M -17.66M -20.8M -16.78M 2.96M -14.38M -12.54M -9.63M
EBIT
n/a -9.36M -12.18M -11.6M -15.14M -15.64M -21.91M -19.5M -18.49M -15.52M -15.11M -17.88M -20.95M -16.96M 2.8M -14.52M -12.69M -9.72M
Depreciation & Amortization
n/a 87K 89K 90K 92K 219K 305K 242K 586K 231K 381K 525K 616K 492K 469K 400K 440K 362K